Home MJN News
The Ministry of Health (MOH) will start administering treatment with the monoclonal antibody drugs Tixagevimab and Cilgavimab (EVUSHELD) in the near …
Read more >>
Etiam placerat velit vitae dui blandit sollicitudin. Vestibulum tincidunt sed dolor sit amet volutpat. Nullam egestas sem at mollis sodales. Nunc …
Read more >>
Etiam placerat velit vitae dui blandit sollicitudin. Vestibulum tincidunt sed dolor sit amet volutpat. Nullam egestas sem at mollis sodales. Nunc …
Read more >>
Etiam placerat velit vitae dui blandit sollicitudin. Vestibulum tincidunt sed dolor sit amet volutpat. Nullam egestas sem at mollis sodales. Nunc …
Read more >>
A total of 1,299,348 children aged five to 11, or 36.6 per cent of the child population in the country have been fully vaccinated under the National COVID-19 Immunisation Programme …
A total of 16,137,205 adults or 68.6 per cent of their population in the country have received the COVID-19 booster dose as of yesterday. Based on the COVIDNOW website, a total …
The Health Ministry (MOH) has taken several temporary solutions to overcome the medicine supply shortage at private clinics and hospitals as well as community pharmacies in the country. Health Minister …
The Ministry of Health (MOH) will start administering treatment with the monoclonal antibody drugs Tixagevimab and Cilgavimab (EVUSHELD) in the near future to ensure that high-risk groups continue to be …
Etiam placerat velit vitae dui blandit sollicitudin. Vestibulum tincidunt sed dolor sit amet volutpat. Nullam egestas sem at mollis sodales. Nunc eget lacinia eros, ut tincidunt nunc. Quisque volutpat, enim …
Etiam placerat velit vitae dui blandit sollicitudin. Vestibulum tincidunt sed dolor sit amet volutpat. Nullam egestas sem at mollis sodales. Nunc eget lacinia eros, ut tincidunt nunc. Quisque volutpat, enim …
Etiam placerat velit vitae dui blandit sollicitudin. Vestibulum tincidunt sed dolor sit amet volutpat. Nullam egestas sem at mollis sodales. Nunc eget lacinia eros, ut tincidunt nunc. Quisque volutpat, enim …